Sickle cell-beta thalassemia

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Sickle cell beta thalassemia
Classification and external resources
ICD-10 D57.40, D57.40, D57.412, D57.419
ICD-9-CM 282.41, 282.42
DiseasesDB 29784

Sickle cell-beta thalassemia (Sickle cell-β thalassemia) is an inherited blood disorder. The disease may range in severity from being relatively benign and like sickle cell trait to being similar to sickle cell disease.[1][2]

Symptoms[edit]

Patients with sickle cell-beta thalassemia may present with painful crises similar to patients with sickle cell disease

Cause[edit]

Sickle cell-beta thalassemia is caused by inheritance of a sickle cell allele from one parent and a beta thalassemia allele from the other.[3]

Mutations[edit]

A sickle allele is always the same mutation of the beta-globin gene (glutamic acid to valine at amino acid six). In contrast, beta-thalassemia alleles can be created by many different mutations including both deletion and non-deletion forms.

Diagnosis[edit]

Patient may present with symptomatic anemia or with sickle crises. In the United States and other countries with new-born screening programs, the disease may be identified in neonates.[4]

Diagnostic tests include DNA sequencing, hemoglobin electrophoresis, and high-performance liquid chromatography.[5]

Treatment[edit]

Treatment is the same as for patients with sickle cell disease. Patients may receive hydroxyurea to induce the protective effects of increased fetal hemoglobin production. They may also benefit from blood transfusions especially during vaso-occlusive crises. Patients may be offered chemoprophylaxis with penicillin. They may have splenic dysfunction and splenectomy is frequently performed. Vaccination against encapsulated bacteria including Streptococcus pneumoniae is recommended.

References[edit]

  1. ^ "Newborn Screening Program - Sickle Cell Beta Thalassemia Disease". www.idph.state.il.us. Retrieved 2015-06-18. 
  2. ^ Ashley-Koch, A; Yang, Q; Olney, R. S. (2000). "Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review". American Journal of Epidemiology. 151 (9): 839–45. doi:10.1093/oxfordjournals.aje.a010288. PMID 10791557. 
  3. ^ "Hemoglobin S– β -Thalassemia Disease - Hematology and Oncology". Retrieved 2015-06-18. 
  4. ^ "Newborn Screening Program - Sickle Cell Beta Thalassemia Disease". www.idph.state.il.us. Retrieved 2015-06-18. 
  5. ^ Ashley-Koch, A; Yang, Q; Olney, R. S. (2000). "Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review". American Journal of Epidemiology. 151 (9): 839–45. doi:10.1093/oxfordjournals.aje.a010288. PMID 10791557.